Ligand validation:1JU9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1JU9 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1JU9_NAD_B_377	16%	38%	0.173	0.809	0.99	1.41	2	3	0	0	61%	1
1JU9_NAD_A_377	12%	36%	0.177	0.774	1.04	1.47	2	2	0	0	61%	1
1HEU_NAD_B_402	100%	7%	0.043	0.993	2.5	2.41	13	11	0	0	100%	1
1QV6_NAD_A_377	98%	38%	0.058	0.977	0.98	1.44	2	6	2	0	100%	1
1A71_NAD_A_403	97%	26%	0.062	0.979	1.35	1.64	4	8	2	0	100%	1
1LDE_NAD_C_377	86%	5%	0.103	0.971	2.36	2.86	17	20	1	0	100%	1
6N7L_NAD_C_402	100%	61%	0.036	0.987	0.62	0.88	-	2	0	0	100%	1
4MPY_NAD_F_501	100%	34%	0.035	0.985	1.3	1.32	3	9	0	0	100%	1
3R3S_NAD_C_300	100%	29%	0.042	0.991	1.25	1.57	3	9	0	0	100%	1
5BR4_NAD_B_402	100%	35%	0.045	0.992	1.44	1.15	7	5	1	0	100%	1
6H0M_NAD_A_302	100%	66%	0.044	0.988	0.56	0.74	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.